3,4-methylenedioxyamphetamine has been researched along with Infarction, Middle Cerebral Artery in 1 studies
3,4-Methylenedioxyamphetamine: An amphetamine derivative that inhibits uptake of catecholamine neurotransmitters. It is a hallucinogen. It is less toxic than its methylated derivative but in sufficient doses may still destroy serotonergic neurons and has been used for that purpose experimentally.
Infarction, Middle Cerebral Artery: NECROSIS occurring in the MIDDLE CEREBRAL ARTERY distribution system which brings blood to the entire lateral aspects of each CEREBRAL HEMISPHERE. Clinical signs include impaired cognition; APHASIA; AGRAPHIA; weak and numbness in the face and arms, contralaterally or bilaterally depending on the infarction.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zhu, HY | 1 |
| Bin, J | 1 |
| Wang, C | 1 |
| Lin, HB | 1 |
| Zhou, H | 1 |
| Xu, JP | 1 |
1 other study available for 3,4-methylenedioxyamphetamine and Infarction, Middle Cerebral Artery
| Article | Year |
|---|---|
[Effects of piperphentonamine hydrochloride on cognitive deficits in rats induced by cerebral ischemia-reperfusion].
Topics: 3,4-Methylenedioxyamphetamine; Animals; Brain Ischemia; Cognition Disorders; Infarction, Middle Cere | 2011 |